Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Vitamin C users were substantially more likely to use other vitamins/mineral supplements, take more medications, and have higher vitamin D levels.
Source: 3.1. Descriptive Statistics. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Association of Vitamin C Supplementation and Genetic Susceptibility with Multiple Sclerosis Risk: A Prospective Population-Based Cohort Study
Source: Article title.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Association of Vitamin C Supplementation and Genetic Susceptibility with Multiple Sclerosis Risk: A Prospective Population-Based Cohort Study
Cohort study · Nutrients · 2026
Original publication title
Association of Vitamin C Supplementation and Genetic Susceptibility with Multiple Sclerosis Risk: A Prospective Population-Based Cohort Study
© 2026 by the authors.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Background/Objectives: Multiple sclerosis (MS) is a chronic immune-mediated neurological disorder for which few modifiable risk factors are established. Vitamin C, due to its antioxidant and neuroprotective properties, has been hypothesized to reduce MS risk, but epidemiological evidence remains inconsistent. Methods: We conducted a prospective cohort study using UK Biobank data, including 486,908 adults aged 37 to 70 years free of neurological disease. Regular vitamin C supplementation was self-reported at recruitment. Incident MS cases were identified during a median follow-up of 13.5 years.
Propensity score weighting was used to balance a wide range of demographic, lifestyle, and health-related confounders. Weighted Cox proportional hazards models were used to estimate hazard ratios (HRs). Effect modification by polygenic risk score (PRS) for MS was assessed, and multiple sensitivity analyses were performed. Results: During follow-up, 452 participants were diagnosed with MS. Vitamin C supplementation was reported by 8.8% of participants (missingness = 1.5%) and was associated with a lower risk of incident MS (HR = 0.51, [95%CI: 0.32; 0.82], p = 0.004).
The estimate was consistent across multiple sensitivity analyses. The association varied according to genetic susceptibility, with significant nonlinear multiplicative interaction (p = 0.004) and additive interaction (p < 0.001). Specifically, significant associations were observed only among those with average or high MS-PRS. Conclusions: Vitamin C supplementation was associated with a lower risk of incident MS, with the association varying across levels of genetic susceptibility. Although residual confounding cannot be excluded, sensitivity analyses did not identify similar associations for overall supplement use or multivitamin use, providing some reassurance against a generalized healthy-user effect.
Replication in independent cohorts is warranted.
Authors’ abstract
Background/Objectives: Multiple sclerosis (MS) is a chronic immune-mediated neurological disorder for which few modifiable risk factors are established. Vitamin C, due to its antioxidant and neuroprotective properties, has been hypothesized to reduce MS risk, but epidemiological evidence remains inconsistent. Methods: We conducted a prospective cohort study using UK Biobank data, including 486,908 adults aged 37 to 70 years free of neurological disease. Regular vitamin C supplementation was self-reported at recruitment. Incident MS cases were identified during a median follow-up of 13.5 years.
Propensity score weighting was used to balance a wide range of demographic, lifestyle, and health-related confounders. Weighted Cox proportional hazards models were used to estimate hazard ratios (HRs). Effect modification by polygenic risk score (PRS) for MS was assessed, and multiple sensitivity analyses were performed. Results: During follow-up, 452 participants were diagnosed with MS. Vitamin C supplementation was reported by 8.8% of participants (missingness = 1.5%) and was associated with a lower risk of incident MS (HR = 0.51, [95%CI: 0.32; 0.82], p = 0.004).
The estimate was consistent across multiple sensitivity analyses. The association varied according to genetic susceptibility, with significant nonlinear multiplicative interaction (p = 0.004) and additive interaction (p < 0.001). Specifically, significant associations were observed only among those with average or high MS-PRS. Conclusions: Vitamin C supplementation was associated with a lower risk of incident MS, with the association varying across levels of genetic susceptibility. Although residual confounding cannot be excluded, sensitivity analyses did not identify similar associations for overall supplement use or multivitamin use, providing some reassurance against a generalized healthy-user effect.
Replication in independent cohorts is warranted.
Publication and source details
Original title: Association of Vitamin C Supplementation and Genetic Susceptibility with Multiple Sclerosis Risk: A Prospective Population-Based Cohort Study
Andrea Nova; Teresa Fazia; Giovanni Di Caprio; Alice Cinquepalmi; Simone Perna; Mariangela Rondanelli; Luisa Bernardinelli
Nutrients · 2026
* Correspondence: andrea.nova@unipv.itThese authors contributed equally to this work.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T22:05:24.178547+00:00
DOI: 10.3390/nu18142367 · PMC13414532